The results showed that although 18F-PSMA-1007 PET imaging of GL261 tumor-bearing mice was feasible and produced high tumor-to-background ratio, absolute tumor uptake values remained low, suggesting the limited application of the GL261 model for PSMA-directed therapy studies. The gene discussed is FOLH1; the disease is neoplasm.